Trupanion, Inc. TRUP

FY2025 · ended Dec 31, 2025 · Revenue $1.44B, +11.9% YoY · Filed Feb 13, 2026

Trupanion, Inc. (TRUP) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.4 billion. Free cash flow was $75.4 million. As of Jun 30, 2026 it held $399.5 million in cash and investments and $106.9 million in total debt.

Revenue (TTM)
$1.52B
+11.8% vs year-ago TTM
Net income
—
Operating cash flow (TTM)
$94.08M
+34.4% vs year-ago TTM
Free cash flow (TTM)
$82.18M
+34.0% vs year-ago TTM
EPS (TTM)
$0.53
+107.3% vs year-ago TTM
Dividend per share
None
Shares outstanding
43.43M
+2.2% vs prior year
Net cash
$292.57M
as of Jun 30, 2026
Operating margin
1.6%
FY 2026

Company profile

Industry
Hospital & Medical Service Plans (SIC 6324)
Listed as
TRUP (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Seattle, WA
SEC filer status
Large accelerated filer
SEC CIK
1371285
Former names
TRUPANION INC. (until May 2, 2018); VETINSURANCE INTERNATIONAL INC (until Nov 9, 2011)

Other Hospital & Medical Service Plans companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Revenue
$1.4B
$1.3B
$1.1B
$905.2M
$699.0M
Operating income
$13.8M
-$9.5M
-$40.7M
-$43.0M
-$35.2M
Diluted EPS
$0.45
-$0.23
-$1.08
-$1.10
—
Operating cash flow
$89.5M
$48.3M
$18.6M
-$8.0M
$7.5M
Free cash flow
$75.4M
$38.6M
$358,000
-$25.1M
-$4.9M
Total assets
$915.0M
$806.9M
$782.9M
$671.6M
$562.6M
Total liabilities
$531.1M
$483.6M
$479.2M
$366.3M
$230.4M
Stockholders' equity
$383.9M
$323.3M
$303.7M
$305.3M
$332.2M
Cash and investments
$371.7M
$307.8M
$290.0M
$230.2M
$220.5M
Total debt
$115.9M
$127.5M
$127.6M
$68.4M
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Other events
Aug 5, 2026 Aug 5, 2026
8-K Current report
Shareholder vote results
Jun 15, 2026 Jun 10, 2026
8-K Current report
Results of operations
Apr 30, 2026 Apr 30, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 27, 2026 Apr 22, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.